Cell and Gene Manufacturing and Logistics

  1. Take Advantage Of Single-Use Technologies For Microbial Processes 9/29/2023

    Review the capabilities and robustness of a new single-use fermenter in a fast, exponentially growing, high cell density Escherichia coli (E. coli) process.

  2. September's Top Content On Cell & Gene 9/29/2023

    Here is a glimpse of the impactful content, in various formats, Cell & Gene delivered this month.

  3. Single-Use Bioreactors Gain Popularity Worldwide 9/29/2023

    Industry momentum is trending in favor of single-use bioreactors as a plurality of biopharma companies are opting for the disposable version of bioreactors, according to new market research. Let's look at the drivers of this change, regional analysis, and prominent vendors in the space.

  4. In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 9/28/2023

    Discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics, recent progress in lentiviral vector manufacturing, and The Colorado Laboratory and Innovation Manufacturing Building.

  5. Global Market Trends For Oligonucleotide APIs 9/28/2023

    Oligonucleotide APIs belong to a category of compounds that comprise short sequences of DNA or RNA. These compounds can be tailor-made to target an individual gene’s messenger RNAs. This article shares new market research, including a look at the drivers behind growing demand, different types of oligonucleotide APIs, and key players in the space.

  6. Foresight Pro Column For Production-Scale Manufacturing Of Biologics 9/27/2023

    Discover a more cost-effective solution than traditional “pack in place” designs to optimize the production-scale manufacturing of biologics.

  7. Film Types For Corning® Single-Use Containers 9/27/2023

    These single-use containers provide a high quality and cost effective solution, utilize films that have undergone a range of biocompatibility tests, and can be customized to match your needs.

  8. Development Of A Novel Cell Culture Medium For AAV Production 9/26/2023

    Explore the medium development process of a novel cell culture medium for AAV production with multiple HEK293 lineages, which was performed with three different HEK293 cell lines to maximize AAV titers.

  9. In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 9/26/2023

    Discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics, recent progress in lentiviral vector manufacturing, and The Colorado Laboratory and Innovation Manufacturing Building.

  10. Stability To Scalability: The Future Of Viral Vector Therapies 9/26/2023

    Despite advances that have contributed to improvements in viral vector yields, innovation is still needed in the CGT sector to impact product quality and accelerate scale for viral vector production.